AUTHOR=Chan Marcus C. Y. , Fung Kevin K. F. , Ng Wai-Fu , Luk Ho-Ming , Ku Dennis T. L. , Liu Anthony P. Y. TITLE=Case report: Treatment response of NF-1-associated bladder ganglioneuroma to trametinib JOURNAL=Frontiers in Oncology VOLUME=14 YEAR=2024 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1433073 DOI=10.3389/fonc.2024.1433073 ISSN=2234-943X ABSTRACT=

We present the clinical course of a 4-year-old girl with neurofibromatosis type 1-associated, unresectable, symptomatic urinary bladder ganglioneuroma. She was initially trialed on sirolimus without response and subsequently responded to MEK inhibitor trametinib, with improvement clinically and radiographically over 10 months. This report broadens the repertoire of therapeutic strategies for MEK inhibition in diseases related to the MAPK pathway.